UroGen Pharma Ltd. (URGN)
43.62
-1.88
(-4.13%)
USD |
NASDAQ |
Aug 28, 16:00
43.61
-0.01
(-0.02%)
After-Hours: 20:00
UroGen Pharma Debt to Equity Ratio : -1.481 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.481 |
| March 31, 2026 | -1.586 |
| December 31, 2025 | -1.233 |
| September 30, 2025 | -1.126 |
| June 30, 2025 | -1.365 |
| March 31, 2025 | -2.720 |
| December 31, 2024 | -14.19 |
| September 30, 2024 | 4.811 |
| June 30, 2024 | 3.267 |
| March 31, 2024 | -2.467 |
| December 31, 2023 | -1.537 |
| September 30, 2023 | -2.391 |
| June 30, 2023 | -0.7254 |
| March 31, 2023 | -0.8606 |
| December 31, 2022 | -1.120 |
| September 30, 2022 | -1.180 |
| June 30, 2022 | -1.797 |
| March 31, 2022 | -4.217 |
| December 31, 2021 | 0.4431 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.0555 |
| June 30, 2021 | 0.0357 |
| March 31, 2021 | 0.0384 |
| December 31, 2020 | 0.0348 |
| September 30, 2020 | 0.0256 |
| June 30, 2020 | 0.0243 |
| March 31, 2020 | 0.0259 |
| December 31, 2019 | 0.0144 |
| September 30, 2019 | 0.0083 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Insmed, Inc. | 0.9865 |
| Xencor, Inc. | 0.338 |
| MeiraGTx Holdings Plc | 0.521 |
| IDEAYA Biosciences, Inc. | 0.0244 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 252.59M |
| Total Liabilities (Quarterly) | 384.99M |
| Shareholders Equity (Quarterly) | -132.40M |
| Current Ratio | 3.802 |
| Net Debt Paydown Yield | -0.78% |